Title: Role of F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Staging of Colorectal Carcinoma

Authors: Anurag Jain, Aniruddha G Pandit, Maj Braj Kishore, Arun Ravi John, Lt Col Amit Sharma, Abhinav Jaimini

 DOI:  https://dx.doi.org/10.18535/jmscr/v5i1.144

Abstract

Colorectal cancer shows an increasing trend in the incidence in Asian country like India.Complex clinical decisions for management of such patients depends on early diagnosis and correct clinical staging imaging findings, thus reducing the morbidity. Accurate determination of the anatomy and morphology of tumors with extent, tumor size, lymph node involvement, and distant metastasis are valuable. F-18 fluorodeoxyglucose positron emission tomography/computed tomography in Staging of Colorectal  carcinoma that provide information about metabolic activity of tumor and distant metastases can change the management protocols

Our study showed that whole body PET/CT should be done as part of protocol in cases of colorectal carcinoma, for staging work up as well as for evaluating local invasiveness, metastases, recurrence and treatment monitoring.

Keywords: Colorectal carcinoma, FDG PET-CT, Staging.

References

111.      Colorectal Cancer Facts & Figures 2011-2013.

2.      Colorectal Cancer; Guest Editor, Robin P. Boushey, M.D., Ph.D.Clin Colon Rectal Surg 2009;22:191–197.

3.      Peedikayil M C Nair P, Seena SM, Radhakrishnan L, Sadasivan S, Narayanan VA and Balakrishnan V. Colorectal cancer distribution in 220 Indian patients undergoing colonoscopy Ind J Gastroenterol 2009; 28(6): 212-215.

4.      Furukawa H, Ikuma H, Seki A, Yokoe K, Yuen S, Aramaki T, Yamagushi S. Positron emission tomography scanning is not superior to whole body multidetector helical computed tomography in the preoperative staging of colorectal cancer.  Gut 2006 Jul; 55(7): 1007-1011.

5.      Yoo JJ, Lee SH, Ahn BK, Baek SK, Lee SM. Positron Emission Tomography (PET)-Computed Tomography (CT) for Preoperative Staging of Colorectal Cancers. J Korean SocColoproctol 2008 Jun; 24(3):201-206.

6.      Abdel-NabiH,  Doerr RJ,  Lamonica DM,  Cronin VR,  Galantowicz PJ. Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopat-hologic and CT findings. Radiology 1998; 206: 755-760.

7.      Kong G, Jackson C, Koh DM, Lewington V, Sharma B, Brown G, Cunningham D, Cook GJ. The use of 18F-FDG PET/CT in colorectal liver metastases--comparison with CT and liver MRI.Eur J Nucl Med Mol Imaging Jul 2008; 35(7): 1323-9.rewiew literature\ref54.docx.

8.      Selzner M, Hany TF, Wildbrett P, McCormack L, Kadry Z, Clavien PA. Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver? Ann Surg 2004; 240(6):1027-34.

9.      Soyka JD, Veit-Haibach P, Strobel K, Breitenstein S, Tschopp A, Mende KA, Lago MP. Staging pathways in recurrent colorectal carcinoma: is contrast-enhanced 18F-FDG PET/CT the diagnostic tool of choice? J Nucl Med 2008; 49(3):354-361.

10.  Park IJ, Kim IC, Yu CS, Ryu M, and Kim J. Efficacy of PET/CT in the accurate evaluation of primary colorectal carcinoma. Eur J SurgOncol 2006; 32(9):941– 947.

Corresponding Author

Aniruddha G Pandit MBBS, MD, DRM

Senior Advisor Nuclear Medicine, Army Hospital R and R, Delhi 110010

Email: This email address is being protected from spambots. You need JavaScript enabled to view it., Mobile: 09958028030